Palisade Bio (PALI) Other financing activities (2021 - 2026)
Palisade Bio (PALI) reported Other financing activities of $46000.0 for Q1 2026, down 74.16% year-over-year from $178000.0 in Q1 2025, and down 89.55% on a QoQ basis from $440000.0 in Q4 2025.
Palisade Bio (PALI) has 6 years of Other financing activities data on file, last reported at $46000.0 in Q1 2026.
- Quarterly Other financing activities fell 74.16% year-over-year to $46000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.8 million (up 816.53% YoY) and the FY2025 annual result came in at $618000.0, up 7.29% from the prior year.
- Other financing activities retreated to $46000.0 in Q1 2026 per PALI's latest filing, from $440000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $9.3 million in Q3 2025 and bottomed at $46000.0 in Q1 2026.
- The 5-year median for Other financing activities is $331000.0 (2022), against an average of $985285.7.
- The widest annual swing landed in 2023, when Other financing activities plunged 82.99%; it then jumped 13620.59% in 2025.
- Tracing PALI's Other financing activities over 5 years: stood at $294000.0 in 2022, then sank by 82.99% to $50000.0 in 2023, then jumped by 140.0% to $120000.0 in 2024, then surged by 266.67% to $440000.0 in 2025, then sank by 89.55% to $46000.0 in 2026.
- Per Business Quant, the three latest PALI Other financing activities figures stand at $46000.0 (Q1 2026), $440000.0 (Q4 2025), and $9.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,000.00 |
| Mar 31, 2026 | 46,000.00 |
| Dec 31, 2025 | 440,000.00 |
| Dec 31, 2025 | 440,000.00 |
| Sep 30, 2025 | 9.33 Mn |
| Sep 30, 2025 | 9.33 Mn |
| Mar 31, 2025 | 178,000.00 |
| Mar 31, 2025 | 178,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Sep 30, 2024 | 68,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Jun 30, 2024 | 705,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Dec 31, 2023 | 50,000.00 |
| Sep 30, 2023 | 345,000.00 |
| Sep 30, 2023 | 345,000.00 |
| Jun 30, 2023 | 854,000.00 |
| Jun 30, 2023 | 854,000.00 |
| Mar 31, 2023 | 413,000.00 |
| Mar 31, 2023 | 413,000.00 |
| Dec 31, 2022 | 294,000.00 |
| Dec 31, 2022 | 294,000.00 |
| Sep 30, 2022 | 317,000.00 |
| Sep 30, 2022 | 317,000.00 |
| Jun 30, 2022 | 634,000.00 |
| Jun 30, 2022 | 634,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 67,000.00 |
| Sep 30, 2021 | 67,000.00 |
| Jun 30, 2021 | 61,000.00 |
| Jun 30, 2021 | 61,000.00 |
| Mar 31, 2021 | 87,000.00 |
| Mar 31, 2021 | 87,000.00 |